Volume 7, Issue 4, Pages (April 2010)

Slides:



Advertisements
Similar presentations
Visfatin Enhances the Production of Cathelicidin Antimicrobial Peptide, Human β- Defensin-2, Human β-Defensin-3, and S100A7 in Human Keratinocytes and.
Advertisements

CATALASE2 Coordinates SA-Mediated Repression of Both Auxin Accumulation and JA Biosynthesis in Plant Defenses  Hong-Mei Yuan, Wen-Cheng Liu, Ying-Tang.
Volume 24, Issue 3, Pages (March 2006)
Volume 22, Issue 4, Pages e4 (October 2017)
Volume 37, Issue 1, Pages (July 2012)
Volume 26, Issue 3, Pages (March 2007)
Community Behavior and Spatial Regulation within a Bacterial Microcolony in Deep Tissue Sites Serves to Protect against Host Attack  Kimberly M. Davis,
Infection-Induced Intestinal Oxidative Stress Triggers Organ-to-Organ Immunological Communication in Drosophila  Shih-Cheng Wu, Chih-Wei Liao, Rong-Long.
Volume 18, Issue 4, Pages (October 2015)
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
A Toll-Like Receptor 7, 8, and 9 Antagonist Inhibits Th1 and Th17 Responses and Inflammasome Activation in a Model of IL-23-Induced Psoriasis  Weiwen.
Topical ROR Inverse Agonists Suppress Inflammation in Mouse Models of Atopic Dermatitis and Acute Irritant Dermatitis  Jun Dai, Min-Kyung Choo, Jin Mo.
Type I IL-1 Receptor Mediates IL-1 and Intracellular IL-1 Receptor Antagonist Effects in Skin Inflammation  Gaby Palmer, Dominique Talabot-Ayer, Gürkan.
NMD: Nonsense-Mediated Defense
Volume 15, Issue 1, Pages (January 2014)
Michael R. Williams, Teruaki Nakatsuji, James A. Sanford, Alison F
Volume 25, Issue 4, Pages (April 2014)
Volume 15, Issue 1, Pages (January 2014)
Volume 8, Issue 6, Pages (December 2010)
Volume 26, Issue 1, Pages (January 2007)
Volume 11, Issue 6, Pages (June 2012)
Volume 55, Issue 5, Pages (September 2007)
Volume 17, Issue 12, Pages (December 2016)
Staphylococcus aureus Exploits Epidermal Barrier Defects in Atopic Dermatitis to Trigger Cytokine Expression  Teruaki Nakatsuji, Tiffany H. Chen, Aimee.
Activation of TLR2 by a Small Molecule Produced by Staphylococcus epidermidis Increases Antimicrobial Defense against Bacterial Skin Infections  Yuping.
Volume 11, Issue 6, Pages (June 2012)
Volume 4, Issue 4, Pages (October 2008)
Brian Yordy, Norifumi Iijima, Anita Huttner, David Leib, Akiko Iwasaki 
Volume 7, Issue 4, Pages (April 2010)
IL-36γ Induced by the TLR3-SLUG-VDR Axis Promotes Wound Healing via REG3A  Ziwei Jiang, Yuanqi Liu, Changwei Li, Leilei Chang, Wang Wang, Zhenhua Wang,
Volume 22, Issue 6, Pages e5 (December 2017)
Antimicrobial and Healing Efficacy of Sustained Release Nitric Oxide Nanoparticles Against Staphylococcus Aureus Skin Infection  Luis R. Martinez, George.
Volume 20, Issue 1, Pages (July 2016)
Volume 7, Issue 2, Pages (February 2010)
Volume 37, Issue 1, Pages (July 2012)
by Ling-juan Zhang, Christian F. Guerrero-Juarez, Tissa Hata, Sagar P
Heparin-Binding Epidermal-Growth-Factor-Like Growth Factor Activation of Keratinocyte ErbB Receptors Mediates Epidermal Hyperplasia, a Prominent Side-Effect.
Histone Acetylation in Keratinocytes Enables Control of the Expression of Cathelicidin and CD14 by 1,25-Dihydroxyvitamin D3  Jürgen Schauber, Yuko Oda,
Regulation of Fibulin-2 Gene Expression by Integrin α3β1 Contributes to the Invasive Phenotype of Transformed Keratinocytes  Dara S. Missan, Sridar V.
Volume 36, Issue 4, Pages (April 2012)
Expression of Epidermal CAMP Changes in Parallel with Permeability Barrier Status  Marina Rodriguez-Martin, Gemma Martin-Ezquerra, Mao-Qiang Man, Melanie.
S100A15, an Antimicrobial Protein of the Skin: Regulation by E
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 18, Issue 5, Pages (November 2015)
μ-Opioid Receptor and CREB Activation Are Required for Nicotine Reward
Kallikrein Expression and Cathelicidin Processing Are Independently Controlled in Keratinocytes by Calcium, Vitamin D3, and Retinoic Acid  Shin Morizane,
Volume 17, Issue 2, Pages (August 2015)
Volume 10, Issue 5, Pages (November 2011)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Volume 21, Issue 1, Pages (January 2017)
Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
Volume 48, Issue 4, Pages e4 (April 2018)
Volume 17, Issue 12, Pages (December 2016)
Kyungho Park, Peter M. Elias, Melanie Hupe, Andrew W
Volume 22, Issue 5, Pages e5 (November 2017)
CATALASE2 Coordinates SA-Mediated Repression of Both Auxin Accumulation and JA Biosynthesis in Plant Defenses  Hong-Mei Yuan, Wen-Cheng Liu, Ying-Tang.
Volume 10, Issue 1, Pages (July 2011)
Increased Expression of Wnt2 and SFRP4 in Tsk Mouse Skin: Role of Wnt Signaling in Altered Dermal Fibrillin Deposition and Systemic Sclerosis  Julie Bayle,
Collagen Synthesis Is Suppressed in Dermal Fibroblasts by the Human Antimicrobial Peptide LL-37  Hyun Jeong Park, Dae Ho Cho, Hee Jung Kim, Jun Young.
Volume 22, Issue 5, Pages e5 (November 2017)
Induction of Leptin Resistance by Activation of cAMP-Epac Signaling
Linda J. Johnston, Nicholas J.C. King 
Vaccinia Virus F11 Promotes Viral Spread by Acting as a PDZ-Containing Scaffolding Protein to Bind Myosin-9A and Inhibit RhoA Signaling  Yutaka Handa,
Pimecrolimus Enhances TLR2/6-Induced Expression of Antimicrobial Peptides in Keratinocytes  Amanda S. Büchau, Jürgen Schauber, Thomas Hultsch, Anton Stuetz,
Volume 129, Issue 2, Pages (April 2007)
Volume 24, Issue 3, Pages (March 2006)
Volume 6, Issue 4, Pages (October 2009)
The Neuroendocrine Peptide Catestatin Is a Cutaneous Antimicrobial and Induced in the Skin after Injury  Katherine A. Radek, Belen Lopez-Garcia, Melanie.
Life-Saving Degeneracy in the Human Immune System
Michael U. Shiloh, Paolo Manzanillo, Jeffery S. Cox 
Presentation transcript:

Volume 7, Issue 4, Pages 277-289 (April 2010) Neuroendocrine Nicotinic Receptor Activation Increases Susceptibility to Bacterial Infections by Suppressing Antimicrobial Peptide Production  Katherine A. Radek, Peter M. Elias, Laurent Taupenot, Sushil K. Mahata, Daniel T. O'Connor, Richard L. Gallo  Cell Host & Microbe  Volume 7, Issue 4, Pages 277-289 (April 2010) DOI: 10.1016/j.chom.2010.03.009 Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 1 Nicotine Reduces Extractable AMPs from Normal Mouse Skin (A) Vehicle or nicotine-treated mouse skin extracts incubated with agar containing S. aureus ΔmprF. HPLC fractions 3-10 are shown (F3-F10). Right side depicts water and CRAMP peptide as negative and positive controls, respectively. Zone of inhibition refers to the zone of bacterial clearance surrounding the central well. (B) Vehicle or nicotine-treated mouse skin extracts incubated with agarose containing S. aureus MRSA. Same representation as in (A). (C) The zone of inhibition (area in mm2) against S. aureus ΔmprF for fractions 3-16 was quantified. ∗p < 0.05, #p < 0.01 versus vehicle by two-way ANOVA. Data are represented as mean ± SEM. (D) The zone of inhibition (area in mm2) against S. aureus MRSA for fractions 3-16 was quantified. Same representation as in (C). Cell Host & Microbe 2010 7, 277-289DOI: (10.1016/j.chom.2010.03.009) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 2 Unopposed Nicotinic Activation in Chga−/− Mice Reduces Extractable AMPs and Is Reversed by Topical nAChR Antagonist (A) Topically treated vehicle or α-bungarotoxin (100nM) Chga+/+ and Chga−/− mouse skin extracts skin extracts against S. aureus ΔmprF. The zone of inhibition (area in mm2) against S. aureus ΔmprF for fractions 5-16 from Chga+/+ and Chga−/− vehicle-treated skin extracts was quantified. ∗p < 0.05, #p < 0.01 versus vehicle by two-way ANOVA. Data are represented as mean ± SEM. (B) α-Bungarotoxin rescued antimicrobial activity in Chga−/− mouse skin against S. aureus ΔmprF. HPLC fraction 11 is shown from vehicle and α-bungarotoxin-treated Chga+/+ and Chga−/− mice. NS, not significant. (C) Topically treated vehicle or α-bungarotoxin (100 nM) Chga+/+ and Chga−/− mouse skin extracts against S. aureus MRSA. The zone of inhibition (area in mm2) against S. aureus MRSA for fractions 5-16 from Chga+/+ and Chga−/− vehicle-treated skin extracts was quantified. Same representation as in (A). NS, not significant. (D) α-Bungarotoxin effects on Chga−/− mouse skin against S. aureus MRSA. HPLC fraction 11 is shown from vehicle and α-bungarotoxin-treated Chga+/+ and Chga−/− mice. Cell Host & Microbe 2010 7, 277-289DOI: (10.1016/j.chom.2010.03.009) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 3 Mice Lacking Endogenous nAChR Antagonist Are More Susceptible to Cutaneous MRSA Infection (A) Wild-type (Chga+/+) mice were injected intradermally with MRSA. A representative photograph of day 4 lesions is shown. (B) Chga−/− mice were injected intradermally with MRSA and are represented as described in (A). (C) Lesion size in mm2 was calculated for day 4 lesions. ∗p < 0.05 by unpaired t test. (D) Day 4 lesions were excised from Chga+/+ and Chga−/− mice for quantitation of bacteria. The CFU/ml MRSA in day 4 lesions is shown. ∗p < 0.05 by unpaired t test. (E) Kidneys were excised 4 days following injection of MRSA. The CFU/ml MRSA on day 4 is shown. ∗p < 0.05 by unpaired t test. All data are represented as mean ± SEM. Cell Host & Microbe 2010 7, 277-289DOI: (10.1016/j.chom.2010.03.009) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 4 Stress Activates Nicotinic Signaling to Increase Susceptibility to Infection and Mimics Phenotype of Chga−/− Mice (A) Control Chga+/+ mice were injected intradermally with GAS. A representative photograph of day 4 lesions is shown. (B) Control Chga−/− mice were injected intradermally with GAS and are represented as in (A). (C) Lesion size in mm2 was calculated in each group for day 1 and day 4 lesions. ∗p < 0.05 by unpaired t test. (D) Psychological stressed Chga+/+ mice mimic phenotype of control Chga−/− mice. Mice were injected intradermally with GAS and are represented as in (A). (E) Susceptibility to GAS infection in Chga−/− mice is not exacerbated by stress. Psychological stressed Chga−/− mice were injected intradermally with GAS and are represented as in (A). (F) Day 4 lesions were excised from control or stressed Chga+/+ and Chga−/− mice for quantitation of bacteria. The CFU/ml of GAS in day 4 lesions is shown. ∗p < 0.05 by unpaired t test. (G) Wild-type mice were subjected to PS and simultaneously treated topically with vehicle for 3 days and then injected with GAS. A representative photograph of day 4 lesions is shown. (H) Wild-type mice were subjected to PS and simultaneously treated topically with 100 nM α-bungarotoxin for 3 days and then injected with GAS. Lesions are represented as in (G). (I) Lesion size in mm2 was calculated for day 4 lesions. ∗p < 0.05 by unpaired t test. (J) Day 4 lesions were excised for quantitation of bacteria. The CFU/ml of GAS in day 4 lesions is shown. ∗p < 0.05 by unpaired t test. All data are represented as mean ± SEM. Cell Host & Microbe 2010 7, 277-289DOI: (10.1016/j.chom.2010.03.009) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 5 Cathelicidin and Defensin AMPs' Expression Decreases following Increased Nicotinic Activation (A) Chga+/+ and Chga−/− mice were injected intradermally with of GAS. Lesions were excised after 24 hr for analysis of AMP gene expression. The relative expression of cathelicidin (Camp) and human beta-defensins 4 and 14 (DefB4 and DefB14) was calculated by qPCR and normalized to GAPDH. ∗p < 0.05 by unpaired t test. (B) GAS lesions from Chga+/+ (top) and Chga−/− (bottom) mice were subjected to immunofluorescent staining for CRAMP. Images shown at 10x magnification (left) show region magnified at 40x (right), indicated by white box. Scale bar represents 50 μM. (C) GAS lesions from Chga+/+ (top) and Chga−/− (bottom) mice were subjected to immunofluorescent staining for mBD3. Same representation as in (B). (D) GAS lesions immunostained with rabbit IgG. Cell Host & Microbe 2010 7, 277-289DOI: (10.1016/j.chom.2010.03.009) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 6 Cholinergic Activation by Ach Reduces AMP Gene Expression and Antimicrobial Activity in Epidermal Keratinocytes (A) Keratinocytes were stimulated for 24 hr with 1,25 (OH)2 vitamin D3 (VD3) and MALP-2 in the presence or absence of Ach (Ach), catestatin (Cst), or α-bungarotoxin (Bung). Relative mRNA expression of cathelicidin (Camp) (left) and human beta-defensin 2 (DefB2) (right) by qPCR and normalized to GAPDH. ∗p < 0.05 versus VD3+MALP-2 by one-way ANOVA. p > 0.05 with Cst and Bung. (B) Keratinocytes were stimulated as above and cell lysates incubated with S. aureus ΔmprF. Surviving bacteria after 12 hr is shown. ∗p < 0.05 versus VD3+MALP-2 by one-way ANOVA. p > 0.05 with Cst and α-bungarotoxin antagonists. All data are represented as mean ± SEM. (C) Keratinocytes were stimulated as above, and cell lysates were incubated with S. aureus ΔmprF. Surviving bacteria after 12 hr is shown. ∗p < 0.05 versus VD3+MALP-2 by one-way ANOVA. p > 0.05 with Cst and α-Bugarotoxin antagonists. All data are represented by mean ± SEM. Cell Host & Microbe 2010 7, 277-289DOI: (10.1016/j.chom.2010.03.009) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 7 Suppression of Cathelicidin by Cholinergic Signaling Is a Critical Component for the Susceptibility to Cutaneous Infection (A) Stress increases susceptibility to GAS infection in wild-type mice. Wild-type mice were subjected to PS and simultaneously treated topically with vehicle for 3 days and then injected with GAS. A representative photograph of day 4 lesions is shown. (B) Stress does not increase susceptibility to GAS infection in Cramp−/− mice. Mice were subjected to PS and simultaneously treated topically with vehicle for 3 days and then injected with GAS. Lesions are represented as in (A). (C) Wild-type mice are rescued from susceptibility GAS infection by α-bungarotoxin treatment during stress. Mice were subjected to PS and simultaneously treated topically with α-bungarotoxin (α-Bung) for 3 days and then injected with GAS. Lesions are represented as in (A). (D) Cramp−/− mice are not rescued from susceptibility GAS infection by α-bungarotoxin treatment during stress. Mice were subjected to PS and simultaneously treated topically with α-bungarotoxin (α-Bung) for 3 days and then injected with GAS. Lesions are represented as in (A). (E) Lesion size (in mm2) was calculated in each group for day 1 and day 4 lesions. ∗p < 0.05 by unpaired t test. (F) Day 4 lesions were excised from stressed Cramp+/+ and Cram−/− vehicle or α-bungarotoxin-treated mice for quantitation of bacteria. The CFU/ml GAS in day 4 lesions is shown. ∗p < 0.05 by unpaired t test. (G) Spleens were excised from stressed Cramp+/+ and Cramp−/− vehicle or α-bungarotoxin-treated mice 4 days following injection for quantitation of bacteria. The CFU/ml GAS in spleen is shown. ∗p < 0.05 by unpaired t test. All data are represented as mean ± SEM. Cell Host & Microbe 2010 7, 277-289DOI: (10.1016/j.chom.2010.03.009) Copyright © 2010 Elsevier Inc. Terms and Conditions

Cell Host & Microbe 2010 7, 277-289DOI: (10.1016/j.chom.2010.03.009) Copyright © 2010 Elsevier Inc. Terms and Conditions